Found: 12
Select item for more details and to access through your institution.
Development and performance of npde for the evaluation of time-to-event models.
- Published in:
- Pharmaceutical Research, 2018, v. 35, n. 2, p. N.PAG, doi. 10.1007/s11095-017-2291-3
- By:
- Publication type:
- Article
STAT4 is a confirmed genetic risk factor for Sjögren's syndrome and could be involved in type 1 interferon pathway signaling.
- Published in:
- Genes & Immunity, 2010, v. 11, n. 5, p. 432, doi. 10.1038/gene.2010.29
- By:
- Publication type:
- Article
STAT4 is a confirmed genetic risk factor for Sjögren's syndrome and could be involved in type 1 interferon pathway signaling.
- Published in:
- 2010
- By:
- Publication type:
- Correction Notice
Pharmacokinetic and Pharmacodynamic Variability of Fluindione in Octogenarians.
- Published in:
- Clinical Pharmacology & Therapeutics, 2012, v. 91, n. 5, p. 777, doi. 10.1038/clpt.2011.309
- By:
- Publication type:
- Article
PharmML in Action: an Interoperable Language for Modeling and Simulation.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2017, v. 6, n. 10, p. 651, doi. 10.1002/psp4.12213
- By:
- Publication type:
- Article
Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2017, v. 6, n. 2, p. 87, doi. 10.1002/psp4.12161
- By:
- Publication type:
- Article
Combined Analysis of Phase I and Phase II Data to Enhance the Power of Pharmacogenetic Tests.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2016, v. 5, n. 3, p. 123, doi. 10.1002/psp4.12054
- By:
- Publication type:
- Article
Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug Development.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
Current Use and Developments Needed for Optimal Design in Pharmacometrics: A Study Performed Among DDMoRe's European Federation of Pharmaceutical Industries and Associations Members.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2013, v. 2, n. 6, p. 1, doi. 10.1038/psp.2013.19
- By:
- Publication type:
- Article
White Paper: Landscape on Technical and Conceptual Requirements and Competence Framework in Drug/Disease Modeling and Simulation.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2013, v. 2, n. 5, p. 1, doi. 10.1038/psp.2013.16
- By:
- Publication type:
- Article
Overview of model-building strategies in population PK/PD analyses: 2002–2004 literature survey.
- Published in:
- British Journal of Clinical Pharmacology, 2007, v. 64, n. 5, p. 603, doi. 10.1111/j.1365-2125.2007.02975.x
- By:
- Publication type:
- Article
Bioavailability of diazepam after intramuscular injection of its water-soluble prodrug alone or with atropine-pralidoxime in healthy volunteers.
- Published in:
- 2009
- By:
- Publication type:
- journal article